Pregnancy Testing Market, 2012 to 2023
Global Pregnancy Testing Market
Pregnancy testing kits are used for early detection of pregnancy. Home pregnancy tests are simple and easy to use, inexpensive and provide accurate results within minutes. Most of the pregnancy tests are being taken in the home provides. The resulting accuracy is up to 97% to 99% when they are used as per the instructions. Urine pregnancy kit will be used for the detection of HCG hormone, a hormone which is only produced in the body of the pregnant woman. HCG production will be increased in initial days of the pregnancy which will be getting doubled for every 2-3 days in blood. Presence of HCG above a specific range will confirm pregnancy.
Growing awareness regarding the availability of pregnancy test kits and utilization of the self-detection pregnancy kits and benefits has expected to create demand for pregnancy test kits. Moreover, a rise in disposable income, increased healthcare expenditure, adoption of technological advancements to detect pregnancy are few factors enables stimulate the market. However, price sensitivity of pregnancy detection kits is making unaffordable for the women in underdeveloped and developing regions. Lack of technical expertise in a woman is major restraints of the market.
The Global pregnancy testing market is classified on the basis of product, test type, distribution channel, and geography.
Based on product, the pregnancy testing market is segmented as
Pregnancy rapid test kits
Line indicator devices
Digital devices
Fertility rapid test
Based on test type, the Global pregnancy testing market is segmented as
Follicle stimulating hormone (FSH) test
Human chorionic gonadotropin hormone blood test
Urine test
Luteinizing hormone (LH) test
Based on distribution channel, pregnancy testing market is segmented as
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Gynaecology clinics
Hypermarkets or supermarkets
A surge in the number of unintended pregnancies increased awareness among women is expected to offer enormous growth opportunities for the market players. According to World Health Organization statistics, in 2015 over 40% of the pregnancy cases which are reporting every year are unintended & about 10% of the pregnancy cases were of teenage. A rise in the number of unintended pregnancies is expected to create demand for pregnancy test kits. Moreover, increasing promotional campaigns undertaken by the manufacturers like celebrity endorsing in order to influence the rural people about utilization of the pregnancy detection devices is expected to bolster pregnancy testing market growth. The market is growing due to reasons like 99% accuracy rate in identifying HCG levels from the day of an expected period of the women. Manufacturers are focussing on the new product launches, market expansions, mergers, acquisitions and collaborations which are also showing positive influence on the growth of the market.
On the basis of geographical regions, Global Pregnancy Testing Market is segmented into five key regions as Europe, Asia- Pacific, North America, Europe, Middle East & Africa and Latin America. North America is expected to dominate pregnancy testing market owing to high healthcare expenditure and awareness programmes by companies for effective usage of pregnancy test kits. Europe is expected to expand at robust growth rate owing to the high adaptation of the digital pregnancy detecting kits along with the increasing disposable incomes. Asia Pacific is anticipated to show a significant growth owing to the increasing adaptation of pregnancy testing kits in the rural areas. Latin America is also emerging as a significant market owing to the growing awareness regarding benefits of the early pregnancy detection and affordability of pregnancy detection kits.
Some of the players in pregnancy testing market are Procter & Gamble Co (U.S.)., Alere Inc. (U.S.), Church & Dwight (U.S.), Germaine Laboratories (U.S.), SPD Swiss Precision Diagnostics (Switzerland), Piramal Enterprises (India), Abbott Laboratories (U.S.), DCC plc (Ireland), Cardinal Health (U.S.), Prestige Brands Holdings (U.S.), Kent Pharmaceuticals (UK), and Quidel Corporation (U.S.).
In 2015 April, Abbott Laboratories received U.S. FDA approval for its I-STAT TOTAL HCG test for the rapid and accurate detection of HCG hormone in pregnant women
Pregnancy testing kits are used for early detection of pregnancy. Home pregnancy tests are simple and easy to use, inexpensive and provide accurate results within minutes. Most of the pregnancy tests are being taken in the home provides. The resulting accuracy is up to 97% to 99% when they are used as per the instructions. Urine pregnancy kit will be used for the detection of HCG hormone, a hormone which is only produced in the body of the pregnant woman. HCG production will be increased in initial days of the pregnancy which will be getting doubled for every 2-3 days in blood. Presence of HCG above a specific range will confirm pregnancy.
Growing awareness regarding the availability of pregnancy test kits and utilization of the self-detection pregnancy kits and benefits has expected to create demand for pregnancy test kits. Moreover, a rise in disposable income, increased healthcare expenditure, adoption of technological advancements to detect pregnancy are few factors enables stimulate the market. However, price sensitivity of pregnancy detection kits is making unaffordable for the women in underdeveloped and developing regions. Lack of technical expertise in a woman is major restraints of the market.
The Global pregnancy testing market is classified on the basis of product, test type, distribution channel, and geography.
Based on product, the pregnancy testing market is segmented as
Pregnancy rapid test kits
Line indicator devices
Digital devices
Fertility rapid test
Based on test type, the Global pregnancy testing market is segmented as
Follicle stimulating hormone (FSH) test
Human chorionic gonadotropin hormone blood test
Urine test
Luteinizing hormone (LH) test
Based on distribution channel, pregnancy testing market is segmented as
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Gynaecology clinics
Hypermarkets or supermarkets
A surge in the number of unintended pregnancies increased awareness among women is expected to offer enormous growth opportunities for the market players. According to World Health Organization statistics, in 2015 over 40% of the pregnancy cases which are reporting every year are unintended & about 10% of the pregnancy cases were of teenage. A rise in the number of unintended pregnancies is expected to create demand for pregnancy test kits. Moreover, increasing promotional campaigns undertaken by the manufacturers like celebrity endorsing in order to influence the rural people about utilization of the pregnancy detection devices is expected to bolster pregnancy testing market growth. The market is growing due to reasons like 99% accuracy rate in identifying HCG levels from the day of an expected period of the women. Manufacturers are focussing on the new product launches, market expansions, mergers, acquisitions and collaborations which are also showing positive influence on the growth of the market.
On the basis of geographical regions, Global Pregnancy Testing Market is segmented into five key regions as Europe, Asia- Pacific, North America, Europe, Middle East & Africa and Latin America. North America is expected to dominate pregnancy testing market owing to high healthcare expenditure and awareness programmes by companies for effective usage of pregnancy test kits. Europe is expected to expand at robust growth rate owing to the high adaptation of the digital pregnancy detecting kits along with the increasing disposable incomes. Asia Pacific is anticipated to show a significant growth owing to the increasing adaptation of pregnancy testing kits in the rural areas. Latin America is also emerging as a significant market owing to the growing awareness regarding benefits of the early pregnancy detection and affordability of pregnancy detection kits.
Some of the players in pregnancy testing market are Procter & Gamble Co (U.S.)., Alere Inc. (U.S.), Church & Dwight (U.S.), Germaine Laboratories (U.S.), SPD Swiss Precision Diagnostics (Switzerland), Piramal Enterprises (India), Abbott Laboratories (U.S.), DCC plc (Ireland), Cardinal Health (U.S.), Prestige Brands Holdings (U.S.), Kent Pharmaceuticals (UK), and Quidel Corporation (U.S.).
In 2015 April, Abbott Laboratories received U.S. FDA approval for its I-STAT TOTAL HCG test for the rapid and accurate detection of HCG hormone in pregnant women
1. EXECUTIVE SUMMARY
2. GLOBAL PREGNANCY TESTING MARKET INTRODUCTION
2.1. Global Pregnancy Testing Market – Taxonomy
2.2. Global Pregnancy Testing Market –Definitions
2.2.1. Product Type
2.2.2. Test Type
2.2.3. Distribution Channel
3. GLOBAL PREGNANCY TESTING MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Pregnancy Testing Market Dynamics – Factors Impact Analysis
3.6. Global Pregnancy Testing Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL PREGNANCY TESTING MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Pregnancy rapid test kits
5.1.1. Line indicator devices
5.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Digital devices
5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.2. Fertility rapid test
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. GLOBAL PREGNANCY TESTING MARKET FORECAST, BY TEST TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Follicle stimulating hormone (FSH) test
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Human chorionic gonadotropin hormone blood test
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Urine test
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Luteinizing hormone (LH) test
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL PREGNANCY TESTING MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Online Pharmacies
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Gynaecology clinics
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Hypermarkets or supermarkets
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. GLOBAL PREGNANCY TESTING MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Region, 2017 – 2023
9. NORTH AMERICA PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Pregnancy rapid test kits
9.1.1.1. Line indicator devices
9.1.1.2. Digital devices
9.1.2. Fertility rapid test
9.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Follicle stimulating hormone (FSH) test
9.2.2. Human chorionic gonadotropin hormone blood test
9.2.3. Urine test
9.2.4. Luteinizing hormone (LH) test
9.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.3.4. Gynaecology clinics
9.3.5. Hypermarkets or supermarkets
9.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
9.6. North America Pregnancy Testing Market Dynamics – Trends
10. EUROPE PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Pregnancy rapid test kits
10.1.1.1. Line indicator devices
10.1.1.2. Digital devices
10.1.2. Fertility rapid test
10.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Follicle stimulating hormone (FSH) test
10.2.2. Human chorionic gonadotropin hormone blood test
10.2.3. Urine test
10.2.4. Luteinizing hormone (LH) test
10.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.3.4. Gynaecology clinics
10.3.5. Hypermarkets or supermarkets
10.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
10.6. Europe Pregnancy Testing Market Dynamics – Trends
11. ASIA-PACIFIC PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Pregnancy rapid test kits
11.1.1.1. Line indicator devices
11.1.1.2. Digital devices
11.1.2. Fertility rapid test
11.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Follicle stimulating hormone (FSH) test
11.2.2. Human chorionic gonadotropin hormone blood test
11.2.3. Urine test
11.2.4. Luteinizing hormone (LH) test
11.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.3.4. Gynaecology clinics
11.3.5. Hypermarkets or supermarkets
11.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
11.6. Europe Pregnancy Testing Market Dynamics – Trends
12. LATIN AMERICA PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Pregnancy rapid test kits
12.1.1.1. Line indicator devices
12.1.1.2. Digital devices
12.1.2. Fertility rapid test
12.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Follicle stimulating hormone (FSH) test
12.2.2. Human chorionic gonadotropin hormone blood test
12.2.3. Urine test
12.2.4. Luteinizing hormone (LH) test
12.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.3.4. Gynaecology clinics
12.3.5. Hypermarkets or supermarkets
12.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
12.6. Latin America Pregnancy Testing Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Pregnancy rapid test kits
13.1.1.1. Line indicator devices
13.1.1.2. Digital devices
13.1.2. Fertility rapid test
13.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Follicle stimulating hormone (FSH) test
13.2.2. Human chorionic gonadotropin hormone blood test
13.2.3. Urine test
13.2.4. Luteinizing hormone (LH) test
13.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.3.4. Gynaecology clinics
13.3.5. Hypermarkets or supermarkets
13.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
13.6. MEA Pregnancy Testing Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Procter & Gamble Co (U.S.)
14.2.2. Alere Inc. (U.S.)
14.2.3. Church & Dwight (U.S.)
14.2.4. Germaine Laboratories (U.S.)
14.2.5. SPD Swiss Precision Diagnostics (Switzerland)
14.2.6. Piramal Enterprises (India),
14.2.7. Abbott Laboratories (U.S.)
14.2.8. DCC plc (Ireland)
14.2.9. Cardinal Health (U.S.)
14.2.10. Prestige Brands Holdings (U.S.)
14.2.11. Kent Pharmaceuticals (UK)
14.2.12. Quidel Corporation (U.S.).
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL PREGNANCY TESTING MARKET INTRODUCTION
2.1. Global Pregnancy Testing Market – Taxonomy
2.2. Global Pregnancy Testing Market –Definitions
2.2.1. Product Type
2.2.2. Test Type
2.2.3. Distribution Channel
3. GLOBAL PREGNANCY TESTING MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Pregnancy Testing Market Dynamics – Factors Impact Analysis
3.6. Global Pregnancy Testing Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL PREGNANCY TESTING MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Pregnancy rapid test kits
5.1.1. Line indicator devices
5.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Digital devices
5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.2. Fertility rapid test
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. GLOBAL PREGNANCY TESTING MARKET FORECAST, BY TEST TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Follicle stimulating hormone (FSH) test
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Human chorionic gonadotropin hormone blood test
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Urine test
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Luteinizing hormone (LH) test
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL PREGNANCY TESTING MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Online Pharmacies
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Gynaecology clinics
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Hypermarkets or supermarkets
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. GLOBAL PREGNANCY TESTING MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Region, 2017 – 2023
9. NORTH AMERICA PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Pregnancy rapid test kits
9.1.1.1. Line indicator devices
9.1.1.2. Digital devices
9.1.2. Fertility rapid test
9.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Follicle stimulating hormone (FSH) test
9.2.2. Human chorionic gonadotropin hormone blood test
9.2.3. Urine test
9.2.4. Luteinizing hormone (LH) test
9.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.3.4. Gynaecology clinics
9.3.5. Hypermarkets or supermarkets
9.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
9.6. North America Pregnancy Testing Market Dynamics – Trends
10. EUROPE PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Pregnancy rapid test kits
10.1.1.1. Line indicator devices
10.1.1.2. Digital devices
10.1.2. Fertility rapid test
10.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Follicle stimulating hormone (FSH) test
10.2.2. Human chorionic gonadotropin hormone blood test
10.2.3. Urine test
10.2.4. Luteinizing hormone (LH) test
10.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.3.4. Gynaecology clinics
10.3.5. Hypermarkets or supermarkets
10.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
10.6. Europe Pregnancy Testing Market Dynamics – Trends
11. ASIA-PACIFIC PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Pregnancy rapid test kits
11.1.1.1. Line indicator devices
11.1.1.2. Digital devices
11.1.2. Fertility rapid test
11.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Follicle stimulating hormone (FSH) test
11.2.2. Human chorionic gonadotropin hormone blood test
11.2.3. Urine test
11.2.4. Luteinizing hormone (LH) test
11.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.3.4. Gynaecology clinics
11.3.5. Hypermarkets or supermarkets
11.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
11.6. Europe Pregnancy Testing Market Dynamics – Trends
12. LATIN AMERICA PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Pregnancy rapid test kits
12.1.1.1. Line indicator devices
12.1.1.2. Digital devices
12.1.2. Fertility rapid test
12.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Follicle stimulating hormone (FSH) test
12.2.2. Human chorionic gonadotropin hormone blood test
12.2.3. Urine test
12.2.4. Luteinizing hormone (LH) test
12.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.3.4. Gynaecology clinics
12.3.5. Hypermarkets or supermarkets
12.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
12.6. Latin America Pregnancy Testing Market Dynamics – Trends
13. MIDDLE EAST AND AFRICA PREGNANCY TESTING MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Pregnancy rapid test kits
13.1.1.1. Line indicator devices
13.1.1.2. Digital devices
13.1.2. Fertility rapid test
13.2. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Follicle stimulating hormone (FSH) test
13.2.2. Human chorionic gonadotropin hormone blood test
13.2.3. Urine test
13.2.4. Luteinizing hormone (LH) test
13.3. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.3.4. Gynaecology clinics
13.3.5. Hypermarkets or supermarkets
13.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Pregnancy Testing Market - Opportunity Analysis Index, By Product Type, By Test , By Distribution Channel, and Country, 2017 – 2023
13.6. MEA Pregnancy Testing Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Procter & Gamble Co (U.S.)
14.2.2. Alere Inc. (U.S.)
14.2.3. Church & Dwight (U.S.)
14.2.4. Germaine Laboratories (U.S.)
14.2.5. SPD Swiss Precision Diagnostics (Switzerland)
14.2.6. Piramal Enterprises (India),
14.2.7. Abbott Laboratories (U.S.)
14.2.8. DCC plc (Ireland)
14.2.9. Cardinal Health (U.S.)
14.2.10. Prestige Brands Holdings (U.S.)
14.2.11. Kent Pharmaceuticals (UK)
14.2.12. Quidel Corporation (U.S.).
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
